Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Diet for Super-refractory Status Epilepticus
NCT07496749Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Oct 2025
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in status epilepticus (SE) (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Time to cessation of super-refractory status epilepticus at 2 weeks. Started Oct 2025; status: recruiting.
02
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT07496749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07496749.